All Relations between cud and cannabis

Publication Sentence Publish Date Extraction Date Species
Guillaume Fond, A Picot, A Bourbon, M Boucekine, P Auquier, C Lançon, L Boye. Prevalence and associated factors of cannabis consumption in medical students: the BOURBON nationwide study. European archives of psychiatry and clinical neuroscience. vol 271. issue 5. 2021-06-28. PMID:32372364. overall, 1642 [14.9 (14.3; 15.6)%] reported cannabis consumption and 622 [5.7 (5.2; 6.1)%] students were identified with cud at screening. 2021-06-28 2023-08-13 human
Guillaume Fond, A Picot, A Bourbon, M Boucekine, P Auquier, C Lançon, L Boye. Prevalence and associated factors of cannabis consumption in medical students: the BOURBON nationwide study. European archives of psychiatry and clinical neuroscience. vol 271. issue 5. 2021-06-28. PMID:32372364. men were at two-time higher risk of cannabis consumption and three-time higher risk of cud (22.4% and 10.6% for men vs. 11.5% and 3.4%, respectively, for women). 2021-06-28 2023-08-13 human
Guillaume Fond, A Picot, A Bourbon, M Boucekine, P Auquier, C Lançon, L Boye. Prevalence and associated factors of cannabis consumption in medical students: the BOURBON nationwide study. European archives of psychiatry and clinical neuroscience. vol 271. issue 5. 2021-06-28. PMID:32372364. in multivariate analyses, men sex, alcohol use disorder, tobacco smoking, parents' divorce, and history of physical assault and lower rates of lower rates of ≥ 40 weekly worked hours were identified as common associated factors for cannabis consumption and cud. 2021-06-28 2023-08-13 human
Guillaume Fond, A Picot, A Bourbon, M Boucekine, P Auquier, C Lançon, L Boye. Prevalence and associated factors of cannabis consumption in medical students: the BOURBON nationwide study. European archives of psychiatry and clinical neuroscience. vol 271. issue 5. 2021-06-28. PMID:32372364. hypnotic consumption, psychiatric follow-up, and history of sexual assault were identified as factors associated specifically with cud, suggesting that these factors were associated with more severe cannabis consumption. 2021-06-28 2023-08-13 human
Chandni Hindocha, Tom P Freeman, Grainne Schafer, Chelsea Gardner, Michael A P Bloomfield, Elvira Bramon, Celia J A Morgan, H Valerie Curra. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme. Addiction biology. vol 25. issue 3. 2021-06-24. PMID:31013550. understanding genetic factors that contribute to cannabis use disorder (cud) is important, but to date, findings have been equivocal. 2021-06-24 2023-08-13 Not clear
Alannah Hillmer, Caroul Chawar, Stephanie Sanger, Alessia D'Elia, Mehreen Butt, Raveena Kapoor, Flavio Kapczinski, Guillaume Pare, Lehana Thabane, Zainab Samaa. Genetic determinants of cannabis use: a systematic review protocol. Systematic reviews. vol 9. issue 1. 2021-06-24. PMID:32819433. cannabis has been known to have several health implications, one of which is the development of cannabis use disorder (cud). 2021-06-24 2023-08-13 Not clear
Melanie L Hill, Mallory Loflin, Brandon Nichter, Sonya B Norman, Robert H Pietrza. Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019-2020 National Health and Resilience in Veterans Study. Addictive behaviors. vol 120. 2021-06-24. PMID:33964583. to provide updated estimates of the prevalence and correlates of cannabis use, cannabis use disorder (cud), and medical cannabis card possession in this population, data were analyzed from the 2019-2020 national health and resilience in veterans study, a nationally representative survey of 4,069 veterans ages 22-99 years who reported on their past-6-month cannabis use, cud symptoms, and possession of a medical cannabis card. 2021-06-24 2023-08-13 Not clear
Melanie L Hill, Mallory Loflin, Brandon Nichter, Sonya B Norman, Robert H Pietrza. Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019-2020 National Health and Resilience in Veterans Study. Addictive behaviors. vol 120. 2021-06-24. PMID:33964583. an estimated 11.9% [95% confidence interval (ci) = 10.9-12.9%)] of veterans reported using cannabis, 2.7% (95% ci = 2.3-3.3%) screened positive for cud, and 1.5% (95% ci = 1.2-2.0%) reported possessing a medical card. 2021-06-24 2023-08-13 Not clear
Melanie L Hill, Mallory Loflin, Brandon Nichter, Sonya B Norman, Robert H Pietrza. Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019-2020 National Health and Resilience in Veterans Study. Addictive behaviors. vol 120. 2021-06-24. PMID:33964583. prevalence of cannabis use, cud, and card possession were higher among younger veterans (use: 20.2%, cud: 5.6%, card: 2.1%) and those with psychiatric conditions (use: 24.0%-30.0%, cud: 8.9%-13.0%, card: 3.1%-4.0%). 2021-06-24 2023-08-13 Not clear
Melanie L Hill, Mallory Loflin, Brandon Nichter, Sonya B Norman, Robert H Pietrza. Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019-2020 National Health and Resilience in Veterans Study. Addictive behaviors. vol 120. 2021-06-24. PMID:33964583. younger age, alcohol use disorder, and childhood adversity explained a large proportion of variance in cannabis use and cud, and depression was independently associated with cud (odds ratio [or] = 2.76). 2021-06-24 2023-08-13 Not clear
Richard J Macatee, Brian J Albanese, Sarah A Okey, Kaveh Afshar, Meghan Carr, M Zachary Rosenthal, Norman B Schmidt, Jesse R Cougl. Impact of a computerized intervention for high distress intolerance on cannabis use outcomes: A randomized controlled trial. Journal of substance abuse treatment. vol 121. 2021-06-23. PMID:33357604. prevalence of regular cannabis use and cannabis use disorder (cud) have increased in the past two decades, but treatment-seeking is low and extant brief interventions do not target causal risk factors implicated in etiological models of addiction. 2021-06-23 2023-08-13 Not clear
Richard J Macatee, Brian J Albanese, Sarah A Okey, Kaveh Afshar, Meghan Carr, M Zachary Rosenthal, Norman B Schmidt, Jesse R Cougl. Impact of a computerized intervention for high distress intolerance on cannabis use outcomes: A randomized controlled trial. Journal of substance abuse treatment. vol 121. 2021-06-23. PMID:33357604. elevated distress intolerance (di) is one risk factor that has been empirically linked with greater cud severity and maintenance in regular users, but, to our knowledge, research has never targeted it in a brief intervention among cannabis users with cud or at high risk. 2021-06-23 2023-08-13 Not clear
Mehdi Akbari, Mohammad Hossein Bahadori, Shahram Mohammadkhani, Daniel C Kolubinski, Ana V Nikčević, Marcantonio M Spad. A discriminant analysis model of psychosocial predictors of problematic Internet use and cannabis use disorder in university students. Addictive behaviors reports. vol 14. 2021-06-19. PMID:34141856. the present study was designed to explore which of a series of psychosocial predictors of addictive behaviors could differentiate problematic internet use (piu) and cannabis use disorder (cud) in a sample of university students. 2021-06-19 2023-08-13 human
Taeho Greg Rhee, Robert A Rosenhec. Associations of Current and Remitted Cannabis Use Disorder With Health-related Quality of Life and Employment Among US Adults. Journal of addiction medicine. 2021-06-19. PMID:34145190. the associations of current and remitted cannabis use disorder (cud) with health-related quality of life (hrqol) and employment have not been studied, and we aim to address these gaps. 2021-06-19 2023-08-13 Not clear
Laila Al-Soufi, Javier Costa. Colocalization of association signals at nicotinic acetylcholine receptor genes between schizophrenia and smoking traits. Drug and alcohol dependence. vol 220. 2021-06-18. PMID:33454625. chrna2 was also associated with cannabis use disorder (cud). 2021-06-18 2023-08-13 Not clear
Dylan K Richards, Frank J Schwebel, Melissa Sotelo, Matthew R Pearso. Self-reported symptoms of cannabis use disorder: Psychometric testing and validation. Experimental and clinical psychopharmacology. vol 29. issue 2. 2021-06-07. PMID:34043399. cannabis use disorder (cud) is commonly assessed using self-report items based on its symptoms as defined by the diagnostic and statistical manual of mental disorders (dsm) that are scored on a dichotomous scale (yes/no) to indicate symptom presence; however, scoring items on a dichotomy may result in relatively limited sensitivity for research. 2021-06-07 2023-08-13 Not clear
Dylan K Richards, Frank J Schwebel, Melissa Sotelo, Matthew R Pearso. Self-reported symptoms of cannabis use disorder: Psychometric testing and validation. Experimental and clinical psychopharmacology. vol 29. issue 2. 2021-06-07. PMID:34043399. past-month cannabis users (n = 2,077) were recruited from nine universities in nine states throughout the u.s. each item of the srscud loaded saliently onto a single factor of cud symptoms in both exploratory and confirmatory factor analyses. 2021-06-07 2023-08-13 Not clear
R James R Blair, Sahil Bajaj, Noah Sherer, Johannah Bashford-Largo, Ru Zhang, Joseph Aloi, Chris Hammond, Jennie Lukoff, Amanda Schwartz, Jaimie Elowsky, Patrick Tyler, Francesca M Filbey, Matthew Dobbertin, Karina S Blai. Alcohol Use Disorder and Cannabis Use Disorder Symptomatology in Adolescents and Aggression: Associations With Recruitment of Neural Regions Implicated in Retaliation. Biological psychiatry. Cognitive neuroscience and neuroimaging. vol 6. issue 5. 2021-06-03. PMID:33712378. both alcohol use disorder (aud) and cannabis use disorder (cud) have been associated with an increased risk of aggression. 2021-06-03 2023-08-13 Not clear
Seán R Millar, Deirdre Mongan, Bobby P Smyth, Ivan J Perry, Brian Galvi. Relationships between age at first substance use and persistence of cannabis use and cannabis use disorder. BMC public health. vol 21. issue 1. 2021-06-02. PMID:34044802. therefore, the aim of this study was to determine relationships between age at first use of alcohol, tobacco and cannabis and patterns of cannabis use, frequency of use and whether age of substance use onset is related to having a cannabis use disorder (cud). 2021-06-02 2023-08-13 Not clear
John J Mariani, Martina Pavlicova, C Jean Choi, Cale Basaraba, Kenneth M Carpenter, Amy L Mahony, Daniel J Brooks, Adam Bisaga, Nasir Naqvi, Edward V Nunes, Frances R Levi. Quetiapine treatment for cannabis use disorder. Drug and alcohol dependence. vol 218. 2021-05-28. PMID:33153828. pharmacotherapy for cannabis use disorder (cud) is an important unmet public health need. 2021-05-28 2023-08-13 Not clear